{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:12:39Z","timestamp":1790230359286,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T00:00:00Z","timestamp":1566950400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T00:00:00Z","timestamp":1566950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","award":["769036"],"award-info":[{"award-number":["769036"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13023-019-1179-1","type":"journal-article","created":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T14:05:25Z","timestamp":1567001125000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia"],"prefix":"10.1186","volume":"14","author":[{"name":"VASCERN-HHT","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. L.","family":"Shovlin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. M.","family":"Millar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Droege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kjeldsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Manfredi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Suppressa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ugolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Coote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. D.","family":"Fialla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Geisthoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. M.","family":"Lenato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. J.","family":"Mager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Pagella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. C.","family":"Post","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Sabb\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Sure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. M.","family":"Torring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Dupuis-Girod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Buscarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,28]]},"reference":[{"key":"1179_CR1","unstructured":"Hereditary haemorrhagic telangiectasia, available at \n                    www.orpha.net\/consor\/www\/cgi-bin\/OC_Exp.php?lng=EN&Expert=774\n                    \n                  . Accessed 19 Aug 2019."},{"issue":"1","key":"1179_CR2","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13023-018-0850-2","volume":"13","author":"CL Shovlin","year":"2018","unstructured":"Shovlin CL, Buscarini E, Kjeldsen AD, Mager HJ, Sabba C, Droege F, Geisthoff U, Ugolini S, Dupuis-Girod S. European reference network for rare vascular diseases (VASCERN) outcome measures for hereditary Haemorrhagic telangiectasia (HHT). Orphanet J Rare Dis. 2018;13(1):136. \n                    https:\/\/doi.org\/10.1186\/s13023-018-0850-2\n                    \n                   Available at \n                    https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-018-0850-2\n                    \n                  .","journal-title":"Orphanet J Rare Dis"},{"issue":"9","key":"1179_CR3","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1513\/AnnalsATS.201603-200OC","volume":"13","author":"W Brinjikji","year":"2016","unstructured":"Brinjikji W, Wood CP, Lanzino G, Cloft HJ, Misra S, Kallmes DF, Kamath P, Pruthi RK, Krowka MJ, Swanson KL, Iyer VN. High rates of bleeding complications among hospitalized patients with hereditary hemorrhagic telangiectasia in the United States. Ann Am Thorac Soc. 2016;13(9):1505\u201311. \n                    https:\/\/doi.org\/10.1513\/AnnalsATS.201603-200OC\n                    \n                  .","journal-title":"Ann Am Thorac Soc"},{"key":"1179_CR4","unstructured":"The European Reference Network for Rare Multisystemic Vascular Diseases (VASCERN), available at \n                    www.vascern.eu\n                    \n                  . Accessed 19 Aug 2019."},{"issue":"5","key":"1179_CR5","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1161\/STROKEAHA.114.007367","volume":"46","author":"H Kim","year":"2015","unstructured":"Kim H, Nelson J, Krings T, terBrugge KG, McCulloch CE, Lawton MT, Young WL, Faughnan ME. Brain vascular malformation consortium HHT Investigator Group. Hemorrhage rates from brain arteriovenous malformation in patients with hereditary hemorrhagic telangiectasia. Stroke. 2015;46(5):1362\u20134. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.114.007367\n                    \n                  . Epub 2015 Apr 9.","journal-title":"Stroke."},{"issue":"5","key":"1179_CR6","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1378\/chest.106.5.1387","volume":"106","author":"BA Ference","year":"1994","unstructured":"Ference BA, Shannon TM, White RI Jr, Zawin M, Burdge CM. Life-threatening pulmonary hemorrhage with pulmonary arteriovenous malformations and hereditary hemorrhagic telangiectasia. Chest. 1994;106(5):1387\u201390.","journal-title":"Chest."},{"issue":"4","key":"1179_CR7","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1136\/thx.40.4.316","volume":"40","author":"W MacNee","year":"1985","unstructured":"MacNee W, Buist TA, Finlayson ND, Lamb D, Miller HC, Muir AL, Douglas AC. Multiple microscopic pulmonary arteriovenous connections in the lungs presenting as cyanosis. Thorax. 1985;40(4):316\u20138.","journal-title":"Thorax."},{"issue":"4","key":"1179_CR8","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/1523-1747.ep12555569","volume":"95","author":"IM Braverman","year":"1990","unstructured":"Braverman IM, Keh A, Jacobson BS. Ultrastructure and three-dimensional organization of the telangiectases of hereditary hemorrhagic telangiectasia. J Invest Dermatol. 1990;95(4):422\u20137.","journal-title":"J Invest Dermatol"},{"issue":"9","key":"1179_CR9","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1111\/j.1471-0528.2008.01786.x","volume":"115","author":"CL Shovlin","year":"2008","unstructured":"Shovlin CL, Sodhi V, McCarthy A, Lasjaunias P, Jackson JE, Sheppard MN. Estimates of maternal risks of pregnancy for women with hereditary haemorrhagic telangiectasia (Osler-weber-Rendu syndrome): suggested approach for obstetric services. BJOG. 2008;115(9):1108\u201315. \n                    https:\/\/doi.org\/10.1111\/j.1471-0528.2008.01786.x\n                    \n                   Epub 2008 May 30.","journal-title":"BJOG."},{"issue":"4","key":"1179_CR10","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1136\/thoraxjnl-2011-201076","volume":"67","author":"JA Livesey","year":"2012","unstructured":"Livesey JA, Manning RA, Meek JH, Jackson JE, Kulinskaya E, Laffan MA, Shovlin CL. Low serum iron levels are associated with elevated plasma levels of coagulation factor VIII and pulmonary emboli\/deep venous thromboses in replicate cohorts of patients with hereditary haemorrhagic telangiectasia. Thorax. 2012;67(4):328\u201333. \n                    https:\/\/doi.org\/10.1136\/thoraxjnl-2011-201076\n                    \n                   Epub 2011 Dec 14.","journal-title":"Thorax."},{"issue":"7","key":"1179_CR11","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1007\/s10620-011-1585-2","volume":"56","author":"E Buscarini","year":"2011","unstructured":"Buscarini E, Leandro G, Conte D, Danesino C, Daina E, Manfredi G, Lupinacci G, Brambilla G, Menozzi F, De Grazia F, Gazzaniga P, Inama G, Bonardi R, Blotta P, Forner P, Olivieri C, Perna A, Grosso M, Pongiglione G, Boccardi E, Pagella F, Rossi G, Zambelli A. Natural history and outcome of hepatic vascular malformations in a large cohort of patients with hereditary hemorrhagic telangiectasia. Dig Dis Sci. 2011;56(7):2166\u201378 . Epub 2011 Feb 3. PubMed PMID: 21290179; PubMed Central PMCID: PMC3112486. \n                    https:\/\/doi.org\/10.1007\/s10620-011-1585-2\n                    \n                  .","journal-title":"Dig Dis Sci"},{"issue":"3","key":"1179_CR12","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1016\/j.ejim.2012.12.013","volume":"24","author":"I Ginon","year":"2013","unstructured":"Ginon I, Decullier E, Finet G, Cordier JF, Marion D, Saurin JC, Dupuis-Girod S. Hereditary hemorrhagic telangiectasia, liver vascular malformations and cardiac consequences. Eur J Intern Med. 2013;24(3):e35\u20139. \n                    https:\/\/doi.org\/10.1016\/j.ejim.2012.12.013\n                    \n                   Epub 2013 Jan 9.","journal-title":"Eur J Intern Med"},{"key":"1179_CR13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ijcard.2016.04.006","volume":"215","author":"CL Shovlin","year":"2016","unstructured":"Shovlin CL, Awan I, Cahilog Z, Abdulla FN, Guttmacher AE. Reported cardiac phenotypes in hereditary hemorrhagic telangiectasia emphasize burdens from arrhythmias, anemia and its treatments, but suggest reduced rates of myocardial infarction. Int J Cardiol. 2016;215:179\u201385 \n                    https:\/\/www.internationaljournalofcardiology.com\/article\/S0167-5273(16)30679-9\/pdf\n                    \n                  .","journal-title":"Int J Cardiol"},{"key":"1179_CR14","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1182\/blood-2016-07-727032","volume":"128","author":"RE Schutgens","year":"2016","unstructured":"Schutgens RE, van der Heijden JF, Mauser-Bunschoten EP, Mannucci PM. New concepts for anticoagulant therapy in persons with haemophilia. Blood. 2016;128:2471\u20134.","journal-title":"Blood"},{"issue":"9","key":"1179_CR15","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1056\/NEJMc1213554","volume":"368","author":"HL Devlin","year":"2013","unstructured":"Devlin HL, Hosman AE, Shovlin CL. Antiplatelet and anticoagulant agents in hereditary hemorrhagic telangiectasia. N Engl J Med. 2013;368(9):876\u20138 \n                    http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMc1213554\n                    \n                  .","journal-title":"N Engl J Med"},{"key":"1179_CR16","unstructured":"VASCERN Do's and Don'ts Factsheets for Rare Vascular Disease Patients Facing Frequent Situations: Hereditary Haemorrhagic Telangiectasia, available at \n                    https:\/\/vascern.eu\/wp-content\/uploads\/2018\/09\/Fiches_Hereditary-Haemorrhagic-Telangiectasia_FINAL-web.pdf\n                    \n                  . Accessed 19 Aug 2019."},{"issue":"3","key":"1179_CR17","doi-asserted-by":"publisher","first-page":"233","DOI":"10.7861\/clinmedicine.17-3-233","volume":"17","author":"CM Millar","year":"2017","unstructured":"Millar CM, Laffan MA. Drug therapy in anticoagulation: which drug for which patient? Clinical Medicine. 2017;17(3):233\u201344.","journal-title":"Clinical Medicine"},{"key":"1179_CR18","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","volume":"37","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks J, Hindricks G, Manolis AS, Oldgren J, Popescu BA, Schotten U, Van Putte B, Vardas P, ESC Scientific Document Group. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37:2893\u2013962.","journal-title":"Eur Heart J"},{"key":"1179_CR19","unstructured":"National Institute for Health and Care Excellence Clinical Guideline (CG 180) Atrial Fibrillation: Management. 2014, available at \n                    https:\/\/www.nice.org.uk\/guidance\/cg180\n                    \n                  . Accessed 19 Aug 2019."},{"key":"1179_CR20","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","volume":"361","author":"SJ Connolly","year":"2009","unstructured":"Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD. Wallentin L; RE-LY steering committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139\u201351.","journal-title":"N Engl J Med"},{"issue":"10","key":"1179_CR21","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1009638","volume":"365","author":"MR Patel","year":"2011","unstructured":"Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KA, Califf RM, Investigators ROCKETAF. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365(10):883\u201391. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1009638\n                    \n                  . Epub 2011 Aug 10.","journal-title":"N Engl J Med"},{"key":"1179_CR22","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","volume":"369","author":"RP Giugliano","year":"2013","unstructured":"Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldo AL, Ezekowitz MD, Weitz JI, \u0160pinar J, Ruzyllo W, Ruda M, Koretsune Y, Betcher J, Shi M, Grip LT, Patel SP, Patel I, Hanyok JJ, Mercuri M, Antman EM, ENGAGE AF-TIMI 48 Investigators. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013;369:2093\u2013104.","journal-title":"N Engl J Med"},{"key":"1179_CR23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1161\/CIRCULATIONAHA.114.012061","volume":"131","author":"DJ Graham","year":"2015","unstructured":"Graham DJ, Reichman ME, Wernecke M, Zhang R, Southworth MR, Levenson M, Sheu TC, Mott K, Goulding MR, Houstoun M, MaCurdy TE, Worrall C, Kelman JA. Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation. Circulation. 2015;131:157\u201364.","journal-title":"Circulation."},{"key":"1179_CR24","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1001\/jamainternmed.2016.5954","volume":"176","author":"DJ Graham","year":"2016","unstructured":"Graham DJ, Reichman ME, Wernecke M, Hsueh YH, Izem R, Southworth MR, Wei Y, Liao J, Goulding MR, Mott K, Chillarige Y, MaCurdy TE, Worrall C, Kelman JA. Stroke, bleeding, and mortality risks in elderly Medicare beneficiaries treated with dabigatran or rivaroxaban for Nonvalvular atrial fibrillation. JAMA Intern Med. 2016;176:1662\u201371.","journal-title":"JAMA Intern Med"},{"issue":"1","key":"1179_CR25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13023-018-0982-4","volume":"14","author":"E Buscarini","year":"2019","unstructured":"Buscarini E, Botella LM, Geisthoff U, Kjeldsen AD, Mager HJ, Pagella F, Suppressa P, Zarrabeitia R, Dupuis-Girod S, Shovlin CL, VASCERN-HHT. Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia. Orphanet J Rare Dis. 2019;14(1):28. \n                    https:\/\/doi.org\/10.1186\/s13023-018-0982-4\n                    \n                   \n                    https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-018-0982-4\n                    \n                  .","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"1179_CR26","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1002\/lary.20818","volume":"120","author":"JB Hoag","year":"2010","unstructured":"Hoag JB, Terry P, Mitchell S, Reh D, Merlo CA. An epistaxis severity score for hereditary hemorrhagic telangiectasia. Laryngoscope. 2010;120(4):838\u201343. \n                    https:\/\/doi.org\/10.1002\/lary.20818\n                    \n                  .","journal-title":"Laryngoscope."},{"issue":"12","key":"1179_CR27","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1007\/s00277-012-1553-8","volume":"91","author":"CP Edwards","year":"2012","unstructured":"Edwards CP, Shehata N, Faughnan ME. Hereditary hemorrhagic telangiectasia patients can tolerate anticoagulation. Ann Hematol. 2012;91(12):1959\u201368. \n                    https:\/\/doi.org\/10.1007\/s00277-012-1553-8\n                    \n                  .","journal-title":"Ann Hematol"},{"issue":"11","key":"1179_CR28","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJMoa1107039","volume":"365","author":"Christopher B. Granger","year":"2011","unstructured":"Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko a, Verheugt FW, Zhu J, Wallentin L; ARISTOTLE committees and Investigators.. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011;365:981\u2013992.","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"1179_CR29","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/bjh.13583","volume":"173","author":"M Ferreira","year":"2016","unstructured":"Ferreira M, Barsam S, Patel JP, Czuprynska J, Roberts LN, Patel RK, Arya R. Heavy menstrual bleeding on rivaroxaban. Br J Haematol. 2016;173(2):314\u20135. \n                    https:\/\/doi.org\/10.1111\/bjh.13583\n                    \n                   Epub 2015 Jul 27.","journal-title":"Br J Haematol"},{"issue":"5","key":"1179_CR30","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1111\/bjh.14003","volume":"176","author":"B Myers","year":"2017","unstructured":"Myers B, Webster A. Heavy menstrual bleeding on rivaroxaban-comparison with Apixaban. Br J Haematol. 2017;176(5):833\u20135. \n                    https:\/\/doi.org\/10.1111\/bjh.14003\n                    \n                   Epub 2016 Mar 11.","journal-title":"Br J Haematol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1179-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-019-1179-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1179-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T23:18:50Z","timestamp":1598483930000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-019-1179-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,28]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1179"],"URL":"https:\/\/doi.org\/10.1186\/s13023-019-1179-1","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,28]]},"assertion":[{"value":"28 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approvals in place at each VASCERN centre.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"210"}}